What is he best known for?
The fields of study he is best known for:
- Antibiotics
- Bacteria
- Microbiology
Ronald N. Jones mostly deals with Microbiology, Antimicrobial, Antibacterial agent, Broth microdilution and Drug resistance.
Many of his studies involve connections with topics such as Staphylococcus aureus and Microbiology.
His Antimicrobial research integrates issues from Vancomycin and Intensive care medicine.
His research integrates issues of Enterococcus and Etest in his study of Vancomycin.
His Antibacterial agent research includes themes of Enterococcus faecalis, Enterococcus faecium and Cephalosporin.
The study incorporates disciplines such as Tigecycline and Acinetobacter in addition to Broth microdilution.
His most cited work include:
- Nosocomial Bloodstream Infections in United States Hospitals: A Three-Year Analysis (1233 citations)
- Does the use of antibiotics in food animals pose a risk to human health? A critical review of published data (796 citations)
- 10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America (534 citations)
What are the main themes of his work throughout his whole career to date?
Ronald N. Jones mainly investigates Microbiology, Antibacterial agent, Antimicrobial, Broth microdilution and Staphylococcus aureus.
His Microbiology research incorporates elements of Ceftazidime and Vancomycin.
His research in Antibacterial agent focuses on subjects like Ciprofloxacin, which are connected to Levofloxacin.
His Antimicrobial research incorporates themes from Pseudomonas aeruginosa, Antibiotic resistance, Drug resistance and Enterobacteriaceae.
In his research, Enterococcus faecium is intimately related to Enterococcus faecalis, which falls under the overarching field of Broth microdilution.
His Streptococcus pneumoniae research includes elements of Penicillin, Haemophilus influenzae and Virology.
He most often published in these fields:
- Microbiology (84.21%)
- Antibacterial agent (28.32%)
- Antimicrobial (26.93%)
What were the highlights of his more recent work (between 2013-2020)?
- Microbiology (84.21%)
- Broth microdilution (24.74%)
- Staphylococcus aureus (17.98%)
In recent papers he was focusing on the following fields of study:
Ronald N. Jones focuses on Microbiology, Broth microdilution, Staphylococcus aureus, Antimicrobial and Ceftazidime.
Ronald N. Jones has researched Microbiology in several fields, including Klebsiella pneumoniae, Enterobacteriaceae and Linezolid.
His Broth microdilution study combines topics from a wide range of disciplines, such as Telavancin, Potency, Susceptibility testing, Enterobacter and Acinetobacter.
His Staphylococcus aureus research focuses on subjects like Cephalosporin, which are linked to Ceftaroline fosamil.
His Antimicrobial study integrates concerns from other disciplines, such as Klebsiella and Multiple drug resistance.
His work carried out in the field of Ceftazidime brings together such families of science as Proteus mirabilis and Stenotrophomonas maltophilia.
Between 2013 and 2020, his most popular works were:
- Contemporary Diversity of β-Lactamases among Enterobacteriaceae in the Nine U.S. Census Regions and Ceftazidime-Avibactam Activity Tested against Isolates Producing the Most Prevalent β-Lactamase Groups (141 citations)
- Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997-2016. (138 citations)
- Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms (137 citations)
In his most recent research, the most cited papers focused on:
- Antibiotics
- Bacteria
- Internal medicine
Ronald N. Jones mainly focuses on Microbiology, Broth microdilution, Ceftazidime, Klebsiella pneumoniae and Antimicrobial.
His biological study focuses on Meropenem.
The various areas that he examines in his Broth microdilution study include Enterococcus faecium, Streptococcus pneumoniae, Potency, Acinetobacter and Enterococcus faecalis.
His Ceftazidime research is multidisciplinary, incorporating perspectives in Proteus mirabilis, Klebsiella and Stenotrophomonas maltophilia.
Ronald N. Jones is interested in Sentry, which is a branch of Antimicrobial.
In general Staphylococcus aureus, his work in Linezolid and Methicillin-resistant Staphylococcus aureus is often linked to 23S ribosomal RNA linking many areas of study.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
